Lipid lowering and recurrent stroke: another stroke paradox?

被引：10

作者：

Amarenco, P ^{[1
]}

机构：

[1] Hop Xavier Bichat, Dept Neurol, Paris, France

[2] Hop Xavier Bichat, Stroke Ctr, Paris, France

[3] Denis Diderot Univ, Sch Med, Paris, France

来源：

EUROPEAN HEART JOURNAL | 2005年 / 26卷 / 18期

关键词：

D O I：

10.1093/eurheartj/ehi309

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This editorial refers to 'lasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease'(dagger) by A. Patel et al., on page 1910 Blood cholesterol and recurrent stroke, another paradox?

引用

页码：1818 / 1819

页数：2

共 10 条

[1] Statins in stroke prevention and carotid atherosclerosis -: Systematic review and up-to-date meta-analysis [J].

Amarenco, P ;

Labreuche, J ;

Lavallée, P ;

Touboul, PJ .

STROKE, 2004, 35 (12) :2902-2909

[2] Stroke prevention, blood cholesterol, and statins [J].

Amarenco, P ;

Lavallée, P ;

Touboul, PJ .

LANCET NEUROLOGY, 2004, 3 (05) :271-278

[3] Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction [J].

Amarenco, P .

NEUROLOGY, 2001, 57 (05) :S35-S44

[4] Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].

Colhoun, HM ;

Betteridge, DJ ;

Durrington, PN ;

Hitman, GA ;

Neil, HAW ;

Livingstone, SJ ;

Thomason, MJ ;

Mackness, MI ;

Charlton-Menys, V ;

Fuller, JH .

LANCET, 2004, 364 (9435) :685-696

[5]

Collins R, 2004, LANCET, V363, P757

[6] Intensive lipid lowering with atorvastatin in patients with stable coronary disease [J].

LaRosa, JC ;

Grundy, SM ;

Waters, DD ;

Shear, C ;

Barter, P ;

Fruchart, J ;

Gotto, AM ;

Greten, H ;

Kastelein, JJP ;

Shepherd, J ;

Wenger, NK .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14) :1425-1435

[7] Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease [J].

Patel, A ;

Woodward, M ;

Campbell, DJ ;

Sullivan, DR ;

Colman, S ;

Chalmers, J ;

Neal, B ;

MacMahon, S .

EUROPEAN HEART JOURNAL, 2005, 26 (18) :1910-1915

[8]

Qizilbash N, 1995, LANCET, V346, P1647

[9] Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial [J].

Shepherd, J ;

Blauw, GJ ;

Murphy, MB ;

Bollen, ELEM ;

Buckley, BM ;

Cobbe, SM ;

Ford, I ;

Gaw, A ;

Hyland, M ;

Jukema, JW ;

Kamper, AM ;

Macfarlane, PW ;

Meinders, AE ;

Norrie, J ;

Packard, CJ ;

Perry, IJ ;

Stott, DJ ;

Sweeney, BJ ;

Twomey, C ;

Westendorp, RGJ .

LANCET, 2002, 360 (9346) :1623-1630

[10] Design and baseline characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study [J].

Sillesen, H .

CEREBROVASCULAR DISEASES, 2003, 16 (04) :389-395

← 1 →